NSABP Members' Area
Password Protected - Access
Limited to NSABP Participating
Institutions Only
NSABP Foundation, Inc.
General NSABP Information
Contact the NSABP
Pathology Section
Future Meetings
NSABP Newsletters
Media Info on cMYC Study
Media Info on STAR
Employment
Clinical Trials Information
Clinical Trials Overview
Protocol Chart
Never Say Lost
Treatment Trials Information
Protocol B-36
Protocol B-37
Protocol B-39
Protocol B-40
Protocol B-41
Protocol B-42
Protocol C-10
Protocol R-04
Prevention Trials Information
Protocol P-1 - BCPT
Protocol P-2 - STAR
BreastCancerPrevention.com
Bibliography of Publications
Related Web Sites
About the NSABP Web Site
Helper Applications
Links to Major Search Engines
Medical Search Engines
To report problems, ask
questions or make comments,
please send e-mail to:
Webmaster@nsabp.pitt.edu
Protocol B-24
A Clinical Trial to Evaluate the Worth of Tamoxifen in Conjunction with Lumpectomy and Breast Irradiation for the Treatment of Noninvasive Intraductal Carcinoma (DCIS) of the Breast
Specific Aims
The specific aim for this protocol is to determine, for patients with noninvasive intraductal cancer (DCIS), whether lumpectomy and postoperative breast irradiation plus prolonged tamoxifen therapy is more effective than lumpectomy and breast irradiation without tamoxifen in preventing the subsequent occurrence of ipsilateral and contralateral breast cancers
